Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Μορφή: Journal article
Γλώσσα:English
Έκδοση: 2012

Παρόμοια τεκμήρια